October 7, 2024
Business Combination with NextPlat Corp Approved by Shareholders with Anticipated Closing Date of October 1, 2024
August 14, 2024
41% Growth in 340B Contract Service Revenue and Momentum in Prescription Volumes Drive Positive Cashflow from Operations
May 17, 2024
Miami, FL –May 15, 2024 – ProgressiveCare Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for its first quarter ended March 31, 2024. The Company reported record first-quarter revenues of approximately$14.6 million, a 28% increase compared to revenues reported in the first quarter of 2023. The results reflect continued increases in prescription volumes and revenue generated from multiple 340B service contracts secured late last year.
April 11, 2024
Results Driven by 17% Increase in Pharmacy Prescription Revenue and Over 136% Growth in 340B Contract Services Revenue
December 14, 2023
Program Expands PharmcoRx’s Ability to Provide Patient Access to Supplemental Health Insurance Benefits for the In-Pharmacy Purchase of Over-the-Counter Products
April 11, 2024
Miami, FL – November 27 – PharmcoRx Pharmacy, a wholly-owned subsidiary of Progressive Care Inc (OTCQB: RXMD), today announced its expansion of in-pharmacy offerings through an agreement with the Mark Cuban Cost Plus Drug Company (“Cost PlusDrugs”). The Cost Plus Drugs program allows participating patients the ability to purchase generic and branded medicines at their cost plus a low fixed markup.
April 11, 2024
Latest OTC Program Expands PharmcoRx Pharmacy’s Ability to Provide Patients with Access to Additional Healthcare Benefits Covered by Medicare Advantage Plans
November 14, 2023
Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for its third quarter ended September 30, 2023. The Company reported record third-quarter revenues of $12.4 million, a 22% increase in comparison to the prior year period, driven primarily by strong growth at its PharmcoRx pharmacies.
August 14, 2023
340B Contract Revenue Drives Quarterly Top-Line Growth as Operating Income Reaches Record Levels
August 14, 2023
Miami, FL – May 12, 2023 – Progressive CareInc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the first quarter ended March 31, 2023. The Company experienced record quarterly total revenues of $11.4 million, a 13% growth from the prior year period.
May 12, 2023
Miami, FL – May 11, 2023 – Progressive CareInc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced that it has successfully completed a transaction of $1 million investment from NextPlatCorp (NASDAQ: NXPL, NXPLW) (“NextPlat”), a global e-commerce provider.
April 4, 2023
Miami, FL – April 3, 2023 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial results for the year ended December 31, 2022. Total revenue increased to $40.6 million, a 5% growth from the prior year. 2022 Annual Financial Highlights (at or for the year ended December 31, 2022, as compared to at or for the year ended December 31, 2021)
December 30, 2022
Progressive Care Inc. (OTCQB: RXMD and RXMDD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, announced today that its Board of Directors approved a 1-for-200 reverse stock split of its common stock shares and that the common stock shares will begin trading on a split-adjusted basis at the commencement of trading on December 30, 2022. The common stock shares will trade on the OTCQB markets under the symbol “RXMDD”. After 20 days, the symbol will revert to “RXMD”. The Board of Directors also approved a change in the authorized common stock shares from one billion (1,000,000,000) to one hundred million (100,000,000) common stock shares.
November 16, 2022
Miami, FL – November 15, 2022 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, today announced financial and operational results for the three months ended September 30, 2022, and appointment of Charles M. Fernandez as the new Chief Executive Officer.
November 16, 2022
MIAMI, FL – November 9, 2022 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce it has chosen the Salesforce Customer 360 cloud to support initiatives in key business areas including retail, 340B, long-term care, and third-party administration (TPA) services.
November 16, 2022
MIAMI, November 8, 2022 - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, November 14th, 2022.
November 16, 2022
MIAMI, FL – November 1, 2022 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the launch of Remote Patient Monitoring (“RPM”) PharmcoMyRPM, a mobile app and patient portal, and PharmcoRPM, a web portal to help providers remotely manage patients’ chronic disease and transitional care.
November 16, 2022
MIAMI & MISSISSAUGA, Ontario & PHOENIX--(BUSINESS WIRE)-- MedAvail Holdings, Inc. (Nasdaq: MDVL) (“MedAvail”) a technology-based retail pharmacy company, and Progressive Care Inc. (OTCQB: RXMD) ("Progressive Care”) a personalized healthcare services and technology company, are excited to announce a technology agreement to deploy five MedAvail MedCenters in Florida.
October 17, 2022
MIAMI, FL – October 6, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the launch of its 340Metrx Platform to help 340B covered entities increase the number of 340B qualified claims and program savings while supporting compliance efforts.
October 4, 2022
MIAMI, FL – September 15, 2022 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce the appointments of Charles M. Fernandez as its new Chairman of the Board and Rodney Barreto as Vice-Chairman of the Board effective September 13, 2022.
October 4, 2022
MIAMI, FL – September 6, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that it has successfully completed a recapitalization of its debt and a strategic investment by NextPlat Corp. (“NextPlat”) (NASDAQ:NXPL). Dawson James Securities Inc. (“Dawson”) served as the placement agent for this transaction.
October 4, 2022
MIAMI, FL – August 31, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that it has entered into an agreement for a recapitalization of its current debt and a strategic investment by NextPlat Corp. NASDAQ: NXPL (“NextPlat”).
August 12, 2022
Miami, FL – August 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced financial and operational results for the three and six months ended June 30, 2022.
August 12, 2022
Progressive Care Inc. a personalized healthcare services and technology company is excited to announce the redesign and launch of a new logo for their data-driven pharmacy brand.
August 12, 2022
MIAMI, August 5, 2022 - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Thursday, August 11, 2022.
August 12, 2022
MIAMI, FL, May 17, 2022 (GLOBE NEWSWIRE) — via – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced financial and operational results for the three months ended March 31, 2022.
May 17, 2022
Adjusted EBITDA increased by approximately 53%, to $101,646 Miami, FL – May 17, 2022 – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced financial and operational results for the three months ended March 31, 2022.
May 16, 2022
MIAMI, May 13, 2022 - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call for 4:30 PM ET on Tuesday, May 17, 2022.
May 4, 2022
MIAMI, FL – May 4, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce its long term care division gained all the necessary long-term care contracts with major payors.
April 28, 2022
MIAMI, FL – April 27, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce its expansion into the rapidly growing multi-billion dollar Remote Patient Monitoring (“RPM”) space.
April 12, 2022
Miami, FL – April 12, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that, effective April 11, 2022, its Registration Statement on Form 10 filed with the U.S. Securities and Exchange (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”) became automatically effective.
April 5, 2022
Miami, FL – March 29, 2022 – Globe Newswire via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced financial and operational results for the year ended December 31, 2021.
April 1, 2022
MIAMI, March 23, 2022 - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company” or “Progressive Care”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, March 28, 2022.
April 1, 2022
Miami, FL – March 7, 2022 – Globe Newswire via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, is pleased to announce the appointment of industry experts, Courtney Thomas as Logistics Manager at PharmcoRx Logistics and Fulfillment Department, and Andreas Grant as Compliance Manager of the PharmcoRx 340B Program.
April 1, 2022
Miami, FL – February 16, 2022 – Globe Newswire via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, is pleased to announce its expansion into corporate-focused services with enhanced technological capabilities to help businesses manage COVID-19 testing and vaccination in the workplace.
April 1, 2022
Miami, FL – February 10, 2022 – Globe Newswire via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that it filed a Form 10 with the U.S. Securities and Exchange Commission (the “SEC”) to register its shares of common stock under Section 12(g) of the Securities Exchange Act of 1934 (the “Exchange Act”).
April 1, 2022
Miami, FL – February 2, 2022 – (GLOBE NEWSWIRE)-via NewMediaWire – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology provider, is pleased to announce that its PharmcoRx subsidiary’s gained status as one of the 35 approved COVID-19 test vendors in the U.S. for travel to the People’s Republic of China (“China”), for the Beijing Winter Olympic Games.
April 1, 2022
Miami, FL – February 1, 2022 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company” or “Progressive Care”), a personalized healthcare services and technology provider, is pleased to announce it has continued to experience strong demand for its COVID-19 testing. Fourth quarter and annual 2021 COVID-19 testing revenue increased 132% and 620%, to $1.4 million and $4.3 million, respectively.
January 27, 2022
MIAMI, FL – January 27, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has partnered with Aimpoint Digital (www.aimpointdigital.com), a premier Alteryx consulting partner, to accelerate value realization from their analytic investments. Alteryx (www.alteryx.com) is an Analytics Automation company that delivers breakthrough business outcomes via its user-friendly, code-free platform.
April 1, 2022
MIAMI, FL – January 25, 2022 – Progressive Care Inc.(OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that the company has implemented Podium (www.podium.com), a two-way communication platform, to connect patients and medical offices with the company’s entire support team.
April 1, 2022
MIAMI, FL – January 24, 2022 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that on January 20, 2022 (the “Effective Date”), the Company reached an agreement to settle the Company’s demand (the “Company’s Demand”) on December 14, 2021 against two investors, Chicago Venture Partners, L.P. (“CVP”) and Iliad Research and Trading, L.P. (“Iliad,” and together with CVP, the “Investors”), and the response of the Investors to the Company’s Demand received on January 7, 2022 (the “Investors Demand”) as reflected in a complaint they filed against the Company (the “Settlement Agreement”). The Settlement Agreement contains customary terms and conditions and provides for the following in exchange for a mutual release of the Company and the Investors from all alleged claims.
January 4, 2022
MIAMI, FL – December 22, 2021 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has appointed Birute Norkute and Joseph Ziegler to join the Company’s Board of Directors.
December 16, 2021
MIAMI, FLORIDA, Dec. 9, 2021 (GLOBE NEWSWIRE) – via NewMediaWire -- On December 3, 2021, Progressive Care Inc. (the “Company” or “Progressive Care”) held a special meeting of its stockholders (the “Special Meeting”). The record date for stockholders entitled to notice of, and to vote at, the Special Meeting was November 3, 2021. At the close of business on that date, the Company had 535,430,294 shares of common stock, par value $0.0001 (“Common Stock”) outstanding and 51 shares of Series A Preferred Stock (“Preferred Stock”) outstanding, and entitled to be voted at the Special Meeting. At the Special Meeting, the following three proposals were submitted to the Company’s stockholders:
December 4, 2021
Focus on Increasing Awareness and Enhancing Stockholder Value Miami, FL – November 30, 2021 – Globe Newswire via NewMediaWire – Progressive Care, Inc. (OTCQB: RXMD) (the “Company”), a personalized healthcare services and technology provider, today announced that it has retained ClearThink Capital (“ClearThink”), a strategic advisory firm, to develop and deploy a comprehensive investor outreach and communications program.
December 4, 2021
MIAMI, FL – November 24, 2021 – Progressive Care Inc.(OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is proud to announce that the Company has donated and placed one thousand (1,000) Thanksgiving turkeys to residents in need in its surrounding communities.
January 4, 2022
Net Income Up 137%, EBITDA up 136% Year Over Year. Gross Margins Jump to 30% as Third-Party Services and Testing Show Increased Growth
December 4, 2021
MIAMI, November 10, 2021 - Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company (the “Company”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, November 15, 2021.
January 4, 2022
MIAMI, FL – August 17, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce the filing of the Company’s financial performance data for the three and six months ended June 30, 2021, which featured strong growth in Gross Profitability, as well as Revenues from Covid-19 Testing and 340B services.
January 4, 2022
Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call for 4:30 PM ET on Monday, August 16, 2021.
August 10, 2021
MIAMI, FL – July 20, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the launch of the Company’s new myVax Passport, developed in partnership with EagleForce Health, LLC (“EagleForce”).
June 4, 2021
MIAMI, FL – June 4, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company is now accepting Bitcoin as a form of payment for its COVID-19 Rapid Resting services at its PharmcoRx locations.
May 27, 2021
MIAMI, FL – May 27, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, announces that the Company’s board of directors (the “Board”) has decided not to move forward with the reverse stock split previously authorized by the Company’s stockholders in December of 2020.
May 26, 2021
Progressive Care, Inc. invites individual and institutional investors as well as advisors and analysts, to attend its real-time, interactive presentation at the Emerging Growth Conference.
January 4, 2022
MIAMI, FL – May 18, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce the filing of the Company’s financial performance data setting new revenue and earnings records for the three months ended March 31, 2021.
May 12, 2021
MIAMI, May 12, 2021 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, May 17, 2021.
April 22, 2021
MIAMI, FL – April 22, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has gained access to a large inventory of Moderna vaccine doses and will begin immediate distribution to PharmCo customers through both in-store and on-location vaccinations.
April 5, 2021
MIAMI, FL – April 5, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the“Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has surpassed $1million in revenues directly driven by its COVID-19 testing program.
April 1, 2021
MIAMI, FL – April 1, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce the filing of the Company’s audited 2020 financial performance data, closing the books on a momentous year that featured strong execution in the face of historic obstacles, the establishment of new executive leadership, the successful establishment of new scalable strategies, and tremendous gains in net cash, EBITDA, and topline results, which have helped to drive shareholder value so far in 2021.
March 29, 2021
MIAMI, March 29, 2021 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care,” the “Company,” “we,” “our”), is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Thursday, April 1st, 2021.
March 3, 2021
MIAMI, FL, March 3, 2021 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care,” the “Company,” “we,” “our”), a personalized healthcare services and technology company, issues the following Letter to Shareholders from the Chief Executive Officer:
February 24, 2021
MIAMI, FL – February 23, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce its transition its software platform to Newleaf, a best-in-class pharmacy software solution produced by leading pharmacy software and technology provider, Keycentrix (Keycentrix.com).
February 16, 2021
MIAMI, FL – February 16, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce a new partnership with EagleForce Health, LLC to integrate its proprietary telehealth platform (“myVax™”) and develop a platform for the Company’s Digital Passport for COVID-19 Testing and Vaccination results.
February 8, 2021
MIAMI, FL – February 8, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to report performance data for the month of December and the full year of 2020, which featured robust growth in sales and prescriptions, as well as breakout growth in emerging income streams, including 340B administration fees and COVID-19 Rapid Testing services.
February 1, 2021
MIAMI, FL – February 1, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that its new 3,700 square foot Orlando pharmacy has now officially opened for business as a potent full-service location that is also expected to act as a growth hub for rapid results viral testing services, Covid-19 vaccinations, and 340B third-party administration contracting.
January 8, 2021
MIAMI, FL – January 8, 2021 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of November 2020.
December 23, 2020
Miami, FL – December 23, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that the Company has completed its move into its new 11,000 sq ft pharmacy space in Hallandale Beach, FL.
December 17, 2020
MIAMI, FLORIDA - December 17, 2020 - On December 14, 2020, Progressive Care, Inc. (the “Company”) held a special meeting of its stockholders (the “Special Meeting”). The record date for stockholders entitled to notice of, and to vote at, the Special Meeting was October 23, 2020. At the close of business on that date, the Company had 470,272,862 shares of common stock, par value $0.0001 (“Common Stock”) outstanding and 51 shares of Series A Super-Voting preferred stock (“Preferred Stock”) outstanding, and entitled to be voted at the Special Meeting. At the Special Meeting, the following four proposals were submitted to the Company’s stockholders:
December 11, 2020
MIAMI, FL – December 7, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the month of October, which featured a strong jump in operating margins, significant sequential monthly growth in net revenues, and the establishment of sales growth related to rapid results COVID-19 testing.
December 3, 2020
On the call, RXMD management will answer pre-submitted questions and discuss details regarding the recently filed proxy statement.MIAMI, December 3nd 2020 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, December 7th, 2020.
December 2, 2020
MIAMI, FL – December 2nd, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”) is pleased to announce that on November 9th it confidentially submitted a draft Registration Statement on Form S-1 to the Securities and Exchange Commission (the “SEC”) relating to the proposed initial public offering of its common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. The initial public offering is expected to take place after the SEC completes its review process, subject to market and other conditions.
November 23, 2020
MIAMI, FL – November 17, 2020 – Progressive Care Inc. (OTCQB:RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce performance data for the three months ended September 30, 2020, including strong topline and bottom line growth, positive EBITDA, increased margins, and continued strong cash resources on hand at the close of the quarter.
November 5, 2020
MIAMI, FL – November 4, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce preliminary topline performance data for the three- and nine month periods ended September 30, 2020, reflecting strong overall growth in sales and prescriptions, breakout expansion in the Company’s 340B segment, and anticipated progress towards the launch of telemedicine services before year-end.
November 5, 2020
MIAMI, FL – October 29, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that the Letter of Intent (the “LOI”) entered into on September 1, 2020, for the Company to acquire substantially all of MyApps Corp. (“MyApps”) has been terminated by the companies.
November 5, 2020
Progressive Care Inc. is pleased to announce that its Board of Directors has appointed Alan Jay Weisberg as Chief Executive Officer
November 5, 2020
MIAMI, FL – October 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce that ClearMetrX Inc., a wholly-owned subsidiary of the Company, has executed a 340B Data Feed Agreement (the “Agreement”) to expand the total addressable market available to ClearMetrX Inc. as a third-party administrator (“TPA”) for 340B healthcare providers nationwide.
November 5, 2020
MIAMI, FL – October , 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that the Company has launched an aggressive expansion of its COVID-19 testing service registered through the FDA under its Emergency Use Authorization (“EUA”) guidelines, featuring an Antigen testing system that produces rapid detection of the SARS-CoV-2 virus with market-leading accuracy in 15 minutes.
November 5, 2020
MIAMI, FL – October 2nd, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company today announced operational performance data for August 2020, which was flat to down on a year-over-year basis due to a resurgence of Covid-19 factors driving providers to reduce patient visits. However, the Company is pleased to have made important advances toward future growth and continued to build strong positive cash flows.
November 5, 2020
MIAMI, FL – September 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce its new partnership with DeliverSTAT, a provider of an all-in-one pharmacy delivery logistics solution. Progressive Care will continue to make deliveries through its in-house team of drivers, but the DeliverSTAT platform will provide best-in-class integrated functionality to streamline costs, expand margins, and widen Progressive Care’s industry edge in pharmacy delivery customer satisfaction.
November 5, 2020
MIAMI, FL – September 15, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to provide current and prospective shareholders with an update on the hiring process for its new CEO and its acquisition of MyApps Corp. (“MyApps”) (myapps.solutions), a leading developer of healthcare software, which includes the emerging telehealth service app, CallingDr™ (callingdr.com).
November 5, 2020
MIAMI, FL – September 8, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that on September 1, 2020, the Company entered into a Letter of Intent (the “LOI”) to acquire one hundred percent (100%) of MyApps Corp. (“MyApps”) (myapps.solutions), a leading developer of healthcare software, which includes the emerging telehealth service app CallingDr™ (callingdr.com). In addition, Progressive Care will be immediately engaging MyApps to accelerate development of software platforms for ClearMetRX, Progressive Care’s wholly owned data management subsidiary, and its divisions. MyApps is a commercial-stage software developer on pace to record over $1 million in revenues in 2020.
November 5, 2020
MIAMI, FL – August 24, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for July 2020, which continued to demonstrate a trend of robust growth in sales, prescriptions, and 340B income in both sequential monthly and year-over-year terms.
November 23, 2020
MIAMI, FL – August 17, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for the three months and six months ended June 30, 2020.
November 5, 2020
MIAMI, August 11, 2020 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Monday, August 17th, 2020.
November 5, 2020
MIAMI, FL – August 14, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that Shital Parikh Mars, Chief Executive Officer (“CEO”) and member of the Board of Directors (the “Board”), notified the Board of Directors of her resignation from such positions on August 10, 2020, to pursue other opportunities. The Board accepted the resignation on August 13, 2020
November 5, 2020
MIAMI, FL – July 29, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce the expansion of the Company’s PharmCo branded pharmacy operations and presence in the Orlando metropolitan area. The Company is moving out of its current Orlando pharmacy location, which is a 700 square-foot mini-pharmacy operating under the “Five Star” brand designation, to a 3,700 square-foot full-size pharmacy that will open under the PharmCo brand designation.
November 5, 2020
MIAMI, FL – July 23, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for June 2020, along with preliminary fiscal Q2 performance data, both of which demonstrate a continued robust trend of growth in sales, prescriptions, 340B income, and COVID-19 testing service revenues.
November 5, 2020
MIAMI, FL – July 14, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced that it has sold through over 90% of its COVID-19 Antibody testing kits. The Company has ordered additional kits and will be expanding testing to meet increasing needs.
November 5, 2020
MIAMI, FL – June 30, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, today announced the launch of ClearMetrX, the Company’s first wholly-owned data analytics company with services designed to support health care organizations across the country.
November 5, 2020
MIAMI, FL – June 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for May 2020, including strong year-over-year growth in the face of continued intense downward pressure from tightening provider prescription demand, with strong execution, patient growth, and expanding Federally Qualified Health Centers (FQHCs) dispensing fees driving robust systemwide performance.
November 5, 2020
MIAMI, FL – June 22, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, has engaged Daszkal Bolton LLP as its new independent public accounting firm as it undertakes efforts to transition to reporting under the Exchange Act Reporting requirements.
November 5, 2020
MIAMI, FL– June 12, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”),a personalized healthcare services and technology company, is pleased to issue the following progress update as the Company prepares for an exciting second half of 2020.
November 5, 2020
MIAMI, FL– June 1, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”),a personalized healthcare services and technology company, is pleased to announce that the Company has selected Atlas Construction and Management LLC (the “Contractor” or “Atlas”)for the construction project at 400 Ansin Blvd in Hallandale Beach, FL.
November 5, 2020
MIAMI, FL – May 20, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to announce operational performance data for April 2020, which represented a very challenging context given clear COVID-19 factors, but also featured strong growth in net sales, prescriptions filled, 340B income, and total patients served, as well as the nationwide launch of our new e-commerce platform and antibody testing program.
November 5, 2020
Join our CEO, Shital Mars, as she answers the most relevant questions related to COVID-19 regarding reopening, testing, second wave, and more.
November 5, 2020
MIAMI, FL – May 18, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is pleased to report financial results for the quarter ended March 31, 2020, which featured very strong revenue growth, especially considering the unique operating conditions during February and March due to the SARS-CoV-2 global pandemic health crisis. During the associated earnings call, management outlined specific competitive advantages and new initiatives positioning the Company for strong growth across all major metrics throughout 2020.
November 5, 2020
MIAMI, FL – May 14, 2020 – Progressive CareInc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is very pleased to announce that the company has obtained the immediate capacity to market and distribute rapid-results antibody test kits (COVID-19 IgG/IgM) registered through the FDA under its emergency Use Authorization (“EUA”) guidelines for conducting SARS-CoV-2antibody presence and COVID-19 infection diagnosis testing.
November 5, 2020
MIAMI, May 11th 2020 (GLOBE NEWSWIRE) -- Progressive Care Inc. (OTCQB: RXMD), a personalized healthcare services and technology company, is pleased to announce that the Company has scheduled an investor conference call at 4:30 PM ET on Friday, May 15th, 2020.
November 5, 2020
MIAMI, FL – April 30, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is excited to announce that it has expanded the scope of its new ecommerce portal (PharmcoRX.com) to serve the entire US domestic market. The Company started filling and shipping orders nationwide this week.
November 5, 2020
MIAMI, FL – April 23, 2020 – Progressive Care Inc. (OTCQB: RXMD) (“Progressive Care” or the “Company”), a personalized healthcare services and technology company, is very excited to announce the live launch of the Company’s new ecommerce portal, which includes online access to prescriptions, essential goods, personal protection equipment, guidance on COVID-19 prevention and care, information about custom compounding, and access to services for patients, payors, and providers. Please visit PharmcoRX.com to take advantage of this comprehensive online pharmacy solution today.
Copyright 2022 © Progressive care inc.
Forward-looking Statements – This website contains forward-looking statements about our business. These forward-looking statements do not relate strictly to historical or current facts. Forward-looking statements involve risks and uncertainties and include statements regarding, among other things, our projected revenue growth and profitability, our growth strategies and opportunity, anticipated trends in our market and our anticipated needs for working capital. Forward-looking statements are generally identifiable by the use of words like “may,” “will,” “should,” “anticipate,” “estimate,” “plans,” “potential,” “projects,” “continuing,” “ongoing,” “expects,” “management believes,” “we believe,” “we intend” or the negative of these words or other variations on these words or comparable terminology. You should not put undue reliance on these forward-looking statements. Forward-looking statements are subject to known and unknown risks, uncertainties and other factors that may cause actual results to differ materially from those reflected in such statements including: risks associated with current and potential future healthcare reforms; risks relating to technology failures or breaches; aspects of our business which are outside, risks relating to management and key personnel changes including attracting and retaining key personnel; failure to comply with legal and regulatory requirements; risks relating to access to capital and credit markets; risks related to indebtedness; exposure to claims and liabilities; changes in industry pricing benchmarks; and other risks and uncertainties that are described in the Risk Factors section of our recently filed Form 10-12G, including the presentation of financial statements and notes thereto, and other reports we have filed with the U.S. Securities and Exchange Commission. These reports are available at www.sec.gov or by calling our Investor Relations department at (888) 919-7411 ext. 221. Forward-looking statements speak only as of the date they are posted to this website, unless an earlier date is indicated, and we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
Non-GAAP FinancialMeasures–This presentationincludes certain “non-GAAP financial measures” as defined in Regulation G under the Securities Exchange Act of 1934. Schedules are attached that reconcile the non-GAAP financial measures included in this presentation to the most directly comparable financial measures calculatedand presentedin accordancewith Generally Accepted Accounting Principles in the United States. You should carefully read Progressive Care’s periodic and currentfilings on the OTCQB website for definitions and further explanation and disclosure regarding our use of non-GAAP financial measures and such filings should be read in conjunction with this presentation.
Type your name and email and we'll send you RXMD's investor's presentation in the next few minutes!
.png){kind=logo}
